tiprankstipranks
Trending News
More News >

Lynn Tetrault Insider Profile

4 Followers
Lynn Tetrault, Director at NeoGenomics, holds 7.00K shares in Rhythm Pharmaceuticals (Ticker: RYTM), holds 80.65K shares in NeoGenomics (Ticker: NEO), holds ― shares in ACELYRIN, INC. (Ticker: SLRN).
tipranks
Lynn Tetrault

Lynn Tetrault
NeoGenomics (NEO)
Director

Ranked #70,561 out of 102,596 Corporate Insiders

Profitable Transactions

50%
3 out of 6 Profitable Transactions

Average Return

-10.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
55.33%
44.67%
A breakdown of Lynn Tetrault's holdings

Insider Roles

Rhythm Pharmaceuticals
(RYTM)
Director
NeoGenomics
(NEO)
Director
Roles that Lynn Tetrault holds in companies

Most Profitable Insider Trade

Stock:
NeoGenomics
(NEO)
Rating:Informative Sell
Date:Mar 06, 2024 - Mar 06, 2025
Return:+33.20%
The most profitable trade made by Lynn Tetrault

Lynn Tetrault's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NeoGenomics
Jun 03, 2025
Director
Uninformative Buy
89.21K
$500.85K
Rhythm Pharmaceuticals
Jun 23, 2025
Director
Uninformative Buy
245.92K
$620.41K
SLRN
ACELYRIN, INC.
List of latest transactions for each holding click on a transaction to see Lynn Tetrault's performance on stock

Lynn Tetrault insider profile FAQ

What is the percentage of profitable transactions made by Lynn Tetrault?
The percentage of profitable transactions made by Lynn Tetrault is 50%.
    What is the average return per transaction made by Lynn Tetrault?
    The average return per transaction made by Lynn Tetrault is -10.10%.
      What stocks does Lynn Tetrault hold?
      Lynn Tetrault holds: NEO, RYTM, SLRN stocks.
        What was Lynn Tetrault’s latest transaction?
        Lynn Tetrault latest transaction was an Uninformative Buy of $245.92K.
          What was Lynn Tetrault's most profitable transaction?
          Lynn Tetrault’s most profitable transaction was an Informative Sell of NEO stock on March 6, 2024. The return on the trade was 33.20%.
            What is Lynn Tetrault's role in NeoGenomics?
            Lynn Tetrault's role in NeoGenomics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.